Personalised reprogramming to prevent progressive pacemaker-related left ventricular dysfunction: A phase II randomised, controlled clinical trial.

Personalised reprogramming to prevent progressive pacemaker-related left ventricular dysfunction: A phase II randomised, controlled clinical trial.

<h4>Background</h4>Pacemakers are widely utilised to treat bradycardia, but right ventricular (RV) pacing is associated with heightened risk of left ventricular (LV) systolic dysfunction and heart failure. We aimed to compare personalised pacemaker reprogramming to avoid RV pacing with u...

Full description

Bibliographic Details
Main Authors: Maria F Paton, John Gierula, Judith E Lowry, David A Cairns, Kieran Bose Rosling, Charlotte A Cole, Melanie McGinlay, Sam Straw, Rowena Byrom, Richard M Cubbon, Mark T Kearney, Klaus K Witte
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2021-01-01
Series:PLoS ONE
Online Access:https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0259450&type=printable

Internet

https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0259450&type=printable

Similar Items